[Federal Register Volume 68, Number 228 (Wednesday, November 26, 2003)]
[Notices]
[Pages 66442-66447]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-29526]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Grant for Injury Control Research Center

    Announcement Type: New.
    Funding Opportunity Number: 04057.
    Catalog of Federal Domestic Assistance Number: 93.136.
    Key Dates:
    Letter of Intent Deadline: December 26, 2003.
    Application Deadline: February 23, 2004.

I. Funding Opportunity Description

    Authority: This program is authorized under sections 301(a) and 
391(a)(1) of the Public Health Service Act, (42 U.S.C. 
241(a)280b(a)(1)), as amended.
    Purpose: The Centers for Disease Control and Prevention (CDC) 
announces the availability of fiscal year (FY) 2004 funds for a grant 
for an Injury Control Research Center (ICRC). This program addresses 
the ``Healthy People 2010'' focus area of Injury and Violence 
Prevention. A copy of ``Healthy People 2010'' is available at the 
following Internet address: http://www.health.gov/healthypeople.
    The purposes of this program are:
    1. To support an ICRC in a state predominately comprised of 
economically depressed rural communities where a relatively large 
portion of the work force is engaged in underground mining, family 
farming, and other rural occupations.
    2. To support injury prevention and control research on priority 
issues as delineated in: ``Healthy People 2010''; ``Reducing the Burden 
of Injury: Advancing Prevention and Treatment''; and the research 
priorities published in the CDC Injury Research Agenda, located at 
http://www.cdc.gov/ncipc.
    3. To integrate, in the context of a national program, the 
disciplines of epidemiology, medicine, biomechanics and other 
engineering, biostatistics, public health, law and criminal justice, 
and behavioral and social sciences in order to prevent and control 
injuries more effectively.
    4. To define the injury problem; identify risk and protective 
factors; develop and evaluate prevention and control interventions and 
strategies; and ensure widespread adoption of effective interventions 
and strategies.
    5. To provide technical assistance to injury prevention and control 
programs within a geographic region.
    Measurable outcomes of the program will be in alignment with the 
following performance goal for the National Center for Injury 
Prevention and Control: Conduct a targeted program of research to 
reduce injury-related death and disability.
    Research Objectives: Center funding is to be designated for two 
types of activities. One type of activity is considered core and 
includes administration, management, general support services (e.g., 
statistical, library, media relations, and advocacy for injury 
prevention and control) as well as activities associated with research 
development, technical assistance, and education (e.g., seed projects, 
training activities, and collaborative and technical assistance 
activities with other groups). Funds may be allocated for trainee 
stipends, tuition remission, and trainee travel in accordance with the 
current rates for the United States Public Health Service agencies. 
Indirect costs for these trainee-related activities are limited to 
eight percent. Defined research projects constitute the second type of 
activity, and ICRCs are encouraged to work toward addressing the 
breadth of the field. Core activities and defined research projects may 
each constitute between 25 percent and 75 percent of the operating 
budget, and should be balanced in such a way that the ICRC demonstrates 
productivity in research as well as teaching and service. Applicants 
with less demonstrated expertise in research are encouraged to devote a 
larger percentage of funds to defined research projects in order to 
establish their capability as research centers of excellence.
    At least 80 percent of the costs (total direct and indirect costs) 
of the approved small and large research projects must be in alignment 
with the ``CDC Injury Research Agenda,'' http://www.cdc.gov/ncipc.
    Eligible applicants may enter into contracts, including consortia 
agreements, as necessary to meet the requirements of the program and 
strengthen the overall application.
    Activities: Awardee activities for this program are as follows:
    1. Applicants must demonstrate expertise and experience in 
conducting and publishing injury research in at least one of the three 
phases of injury control (prevention, acute care, or rehabilitation) 
and are encouraged to be comprehensive.
    2. Applicants must document ongoing injury control-related research 
projects and activities currently supported by other sources of 
funding.
    3. Applicants must provide a director (Principal Investigator) who 
has specific authority and responsibility to carry out the project. The 
director must report to

[[Page 66443]]

an appropriate institutional official, e.g., dean of a school, vice 
president of a university, or commissioner of health. The director must 
have no less than thirty percent effort devoted solely to this project 
with an anticipated range of thirty percent to fifty percent.
    4. Applicants must provide evidence of working relationships, 
including consultation and technical assistance, with outside agencies 
and other entities in the region in which the ICRC is located which 
will allow for implementation and evaluation of any proposed 
intervention activities.
    5. Applicants must provide evidence of involvement of specialists 
or experts in medicine, biomechanics and other engineering, 
epidemiology, law and criminal justice, behavioral and social sciences, 
biostatistics, and public health as needed to complete the plans of the 
center. These are considered the disciplines and fields for ICRCs.
    6. Applicants must have established curricula and graduate training 
programs in disciplines relevant to injury control (see item 5.above.).
    7. Applicants must disseminate injury control research findings, 
translate them into interventions (i.e., programs or policies), and 
evaluate their effectiveness.

II. Award Information

    Type of Award: Grant.
    Fiscal Year Funds: FY 2004.
    Approximate Total Funding: $905,500 (total of direct and indirect 
costs).
    Approximate Number of Awards: One award.
    Approximate Average Award: $905,500.
    Floor of Award Range: None.
    Ceiling of Award Range: Applicants will be allowed to apply for 
$1,055,500 ($150,000 above the expected award amount to allow for the 
inclusion of the description of an additional large project as 
described in Section IV. Application and Submission Information, 
Application 4.b. (2), but the award will be no more than $905,500 
(total of direct and indirect costs).
    Anticipated Award Date: September 1, 2004.
    Budget Period Length: Twelve months.
    Project Period Length: Three years.
    Throughout the project period, CDC's commitment to continuation of 
awards will be conditioned on the availability of funds, evidence of 
satisfactory progress by the recipient (as documented in required 
reports), and the determination that continued funding is in the best 
interest of the Federal Government.

III. Eligibility Information

    1. Eligible applicants: This announcement will provide funding for 
applicants in regions that do not have funded Injury Control Research 
Centers (ICRCs) and for applicants in regions that have funded Centers 
that must re-compete for funding.
    Eligible applicants are limited to organizations in Department of 
Health and Human Services (DHHS) Region II (New Jersey, New York, 
Puerto Rico, and Virgin Islands), Region III (Delaware, District of 
Columbia, Maryland, Pennsylvania, Virginia, and West Virginia), and 
Region VI (Arkansas, Louisiana, New Mexico, Oklahoma, and Texas).

    Note: ICRC grant awards are made to the applicant institution/
organization, not the Principal Investigator.

    Applications may be submitted by public and private nonprofit and 
for profit organizations and by governments and their agencies, such 
as:

[sbull] Public nonprofit organizations
[sbull] Private nonprofit organizations
[sbull] For profit organizations
[sbull] Small, minority, women-owned businesses
[sbull] Universities
[sbull] Colleges
[sbull] Research institutions
[sbull] Hospitals
[sbull] Community-based organizations
[sbull] Faith-based organizations
[sbull] Federally recognized Indian tribal governments
[sbull] Indian tribes
[sbull] Indian tribal organizations
[sbull] State and local governments or their Bona Fide Agents (this 
includes the District of Columbia)
[sbull] Political subdivisions of States (in consultation with States)

    A Bona Fide Agent is an agency/organization identified by the state 
as eligible to submit an application under the state eligibility in 
lieu of a state application. If you are applying as a bona fide agent 
of a state or local government, you must provide a letter from the 
state or local government as documentation of your status. Place this 
documentation behind the first page of your application form.
    2. Cost Sharing or Matching: Matching funds are not required for 
this program.
    3. Other Eligibility Requirements: If you request a funding amount 
greater than the ceiling of the award range ($1,055,500), your 
application will be considered non-responsive and will not be entered 
into the review process. You will be notified that you did not meet the 
submission requirements.

    Note: Title 2 of the United States Code section 1611 states that 
an organization described in section 501(c)(4) of the Internal 
Revenue Code that engages in lobbying activities is not eligible to 
receive Federal funds constituting an award, grant, or loan.

IV. Application and Submission Information

    1. Address to Request Application Package: To apply for this 
funding opportunity, use application form PHS 398 (OMB number 0925-0001 
rev. 5/2004). Forms and instructions are available in an interactive 
format on the CDC web site, at the following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm.
    Forms and instructions are also available in an interactive format 
on the National Institutes of Health (NIH) web site at the following 
Internet address: http://grants.nih.gov/grants/funding/phs398/phs398.html.
    If you do not have access to the Internet, or if you have 
difficulty accessing the forms on-line, you may contact the CDC 
Procurement and Grants Office Technical Information Management Section 
(PGO-TIM) staff at: (770) 488-2700. Application forms can be mailed to 
you.

2. Content and Form of Application Submission:

    Letter of Intent (LOI): CDC requests that you send a LOI if you 
intend to apply for this program. Although the LOI is not required, not 
binding, and does not enter into the review of your subsequent 
application, your LOI will be used to gauge the level of interest in 
this program, and to allow CDC to plan the application review. Your LOI 
must be written in the following format:

[sbull] Maximum number of pages: Two
[sbull] Font size: 12-point unreduced
[sbull] Single Spaced
[sbull] Paper size: 8.5 by 11 inches
[sbull] Page margin size: one inch
[sbull] Printed only on one side of page
[sbull] Written in English, avoid jargon

Your LOI must contain the following information:

[sbull] Descriptive title of the proposed research
[sbull] Name, address, email address, and telephone number of the 
Principal Investigator
[sbull] Names of other key personnel
[sbull] Participating institutions
[sbull] Number and title of this Program Announcement (PA)

    Application:  Follow the PHS 398 application instructions for 
content and formatting of your application. For further assistance with 
the PHS 398 application form, contact GrantsInfo, Telephone (301) 435-
0714, E-mail: [email protected].

[[Page 66444]]

    Your research plan should address activities to be conducted over 
the entire project period.
    You are required to have a Dun and Bradstreet Data Universal 
Numbering System (DUNS) number to apply for a grant or cooperative 
agreement from the Federal government. Your DUNS number must be entered 
in item 11 of the face page of the PHS 398 application form. The DUNS 
number is a nine-digit identification number, which uniquely identifies 
business entities. Obtaining a DUNS number is easy and there is no 
charge. To obtain a DUNS number, access http://www.dunandbradstreet.com 
or call 1-866-705-5711. For more information, see the CDC web site at: 
http://www.cdc.gov/od/pgo/funding/pubcommt.htm.
    The Program Announcement title and number must appear in the 
application. Use the information in Section I. Funding Opportunity 
Description, Activities; Section V. Application Review Information; and 
Section VI. Award Administration Information, Administration and 
National Policy Requirements to develop the application content. 
Applications should include the following information, detailing 
activities to be conducted for the first budget year, while briefly 
addressing activities to be conducted over the entire three-year 
project period.
    1. Face page.
    2. Description (abstract) and personnel.
    3. Table of contents.
    4. Detailed budget for the initial budget period: The budget should 
reflect the composite figures for the grant. In addition, separate 
budgets (direct and indirect costs) and justifications should be 
provided for the following categories of activities:
    a. Core activities, including management and administrative 
functions, other non-research activities (e.g., education/training, 
consultation, technical assistance, translation/dissemination, program 
and policy development and evaluation, advocacy, and media activities, 
etc.), and small seed projects of less than $25,000 (total of direct 
and indirect costs) for one year or less.
    b. Research Studies:
    (1) Small studies of $25,000-150,000/year (total of direct and 
indirect costs) for one to three years duration. These projects might 
be expansions of seed projects, either further developing methods or 
hypotheses in preparation for a larger investigation leading to the 
submission of an RO1 level proposal, or might be stand-alone 
investigations sufficient to yield results worthy of publication in a 
peer-reviewed journal and/or a technical report for a legislative body, 
governmental agency, or injury control program.
    (2) Larger scale studies with annual budgets exceeding $150,000/
year (total of direct and indirect costs) and lasting up to three 
years. These projects typically will test hypotheses and employ more 
sophisticated methodologies and/or larger sample sizes than small 
studies.
    For seed projects, only modest budget descriptions are required 
within the application. More detailed budget descriptions, commensurate 
with costs, are required for both small studies and large research 
projects.
    An applicant organization has the option of having specific salary 
and fringe benefit amounts for individuals omitted from the copies of 
the application that are made available to outside reviewing groups. To 
exercise this option: On the original and two copies of the 
application, the applicant must use asterisks to indicate those 
individuals for whom salaries and fringe benefits are not shown; the 
subtotals must still be shown. In addition, the applicant must submit 
an additional copy of page four of Form PHS-398, completed in full, 
with the asterisks replaced by the salaries and fringe benefits. This 
budget page will be reserved for internal staff use only.
    5. Budget for entire proposed project period including budgets 
pertaining to consortium/contractual arrangements.
    6. Biographical sketches of key personnel, consultants, and 
collaborators, beginning with the Principal Investigator and core 
faculty.
    7. Other support: This listing should include all other funds or 
resources pending or currently available. For each grant or contract 
include source of funds, amount of funding (indicate whether pending or 
current), date of funding (initiation and termination), and 
relationship to the proposed program.
    8. Resources and environment.
    9. Research plan:
    a. ICRCs are to develop a range of research and other non-research 
activities that are designed to advance the field of injury control 
through development of new scientific or surveillance methods, creation 
of new knowledge, and translation of knowledge into training, program 
and policy development and evaluation activities or other applications 
that will ultimately reduce injuries or their effects. ICRC 
applications should articulate how the activities of their program are 
integrated with each other.
    b. A detailed research plan (design and methods), in accordance 
with NCIPC's performance goal as stated in the purpose section of this 
announcement, including hypothesis, expected outcome, value to the 
field, and measurable and time-framed objectives consistent with the 
activities for each project within the proposed grant.
    (1) Initial seed projects require a short write-up describing the 
injury control context of the study, the objective, the design, the 
setting and participants, the intervention being addressed, main 
outcome measurements, expected results, time lines, cost (total of 
direct and indirect costs), plans for translation/dissemination, and 
clear definition of procedures used to select the projects. Clear 
definitions of procedures used to select future out-year seed projects 
are also required.
    (2) Small research projects require a ten to fifteen page summary 
describing the accomplishment of all the steps, including a description 
of the significance of the project, the development and testing of 
methods and instruments, and the collection of preliminary data needed 
to take an innovative approach and develop it to the level of a larger 
investigation leading to the submission of an RO1 level proposal or a 
stand-alone investigation sufficient to yield results worthy of 
publication in a peer-reviewed journal and/or a technical report for a 
legislative body, governmental agency, or injury control program.
    (3) Large research projects require an RO1 level summary as 
described in the PHS 398 (Revised 5/01 and updated 6/28/02) guidelines. 
The summary should be included as an appendix of the application.
    In the research plan section of the application include a 
description for each small and large research project:
    a. Title of Project.
    b. Project Director/Lead Investigator.
    c. Institution(s).
    d. Categorization as Prevention, Acute Care, Rehabilitation, or 
Biomechanics.
    e. Categorization as to which NCIPC research agenda priority area 
the project addresses. Also, a brief description on how it addresses 
that priority area. If a priority area is not addressed, provide an 
explanation of why it is important.
    f. Categorization as Seed Project, Small Project, or Large Project.
    g. Categorization as New or Ongoing Project
    h. Cost/Year (total of direct and indirect costs).
    i. Research Training: Names, Degrees of Persons Trained or in 
Training.
    j. Key Words.

[[Page 66445]]

    k. Brief Summary of Project including Intended Application of 
Finding (Abstract).
    c. A description of the core faculty and their roles in 
implementing and evaluating the proposed programs. The applicant should 
clearly specify how disciplines will be integrated to achieve the 
ICRC's objectives.
    d. Charts showing the proposed organizational structure of the ICRC 
and its relationship to the broader institution of which it is a part 
and, where applicable, to affiliate institutions or collaborating 
organizations. These charts should clearly detail the lines of 
authority as they relate to the center, both structurally and 
operationally. ICRC directors should report to an appropriate 
organizational level (e.g. dean of a school, vice president of a 
university, or commissioner of health), demonstrating strong 
institution-wide support of ICRC activities and ensuring oversight of 
the process of interdisciplinary activity.
    e. Documentation of the public health agencies and other public and 
private sector entities to be involved in the proposed program, 
including letters that detail commitments of support and a clear 
statement of the role, activities, and participating personnel of each 
agency or entity.
    3. Submission Dates and Times:
    LOI Deadline Date: December 26, 2003.
    Application Deadline Date: February 23, 2004.
    Explanation of Deadlines: Applications must be received in the CDC 
Procurement and Grants Office by 4 p.m. Eastern Time on the deadline 
date. If you send your application by the United States Postal Service 
or commercial delivery service, you must ensure that the carrier will 
be able to guarantee delivery of the application by the closing date 
and time. If CDC receives your application after closing due to: (1) 
Carrier error, when the carrier accepted the package with a guarantee 
for delivery by the closing date and time, or (2) significant weather 
delays or natural disasters, you will be given the opportunity to 
submit documentation of the carrier's guarantee. If the documentation 
verifies a carrier problem, CDC will consider the application as having 
been received by the deadline.
    This announcement is the definitive guide on application submission 
address and deadline. It supersedes information provided in the 
application instructions. If your application does not meet the 
deadline above, it will not be eligible for review, and will be 
discarded. You will be notified that you did not meet the submission 
requirements.
    CDC will not notify you upon receipt of your application. If you 
have a question about the receipt of your application, first contact 
your courier. If you still have a question, contact the PGO-TIM staff 
at: 770-488-2700. Before calling, please wait two to three days after 
the application deadline. This will allow time for applications to be 
processed and logged.
    4. Intergovernmental Review: Executive Order 12372 does not apply 
to this program.
    5. Funding restrictions: Restrictions, which must be taken into 
account while writing your budget are as follows:
    Grant funds will not be made available to support the provision of 
direct care. Studies may be supported which evaluate methods of acute 
care and rehabilitation for potential reductions in injury effects and 
costs. Studies may be supported which identify the effect on injury 
outcomes and cost of systems for pre-hospital, hospital, and 
rehabilitative care and independent living.
    If you are requesting indirect costs in your budget, you must 
include a copy of your indirect cost rate agreement. If your indirect 
cost rate is a provisional rate, the agreement must be less than 12 
months of age.
    Awards will not allow reimbursement of pre-award costs.
    6. Other Submission Requirements:
    LOI Submission Address: Submit your LOI by express delivery 
service, fax, or e-mail to (only one submission is required): Robin 
Forbes, Center for Injury Prevention and Control, Centers for Disease 
Control and Prevention (CDC), 4770 Buford Hwy., NE, Mailstop K-62, 
Atlanta, GA 30341, Telephone: 770-488-4037, Fax: 770-488-1662, Email: 
[email protected].
    Application Submission Address: Submit the original and five copies 
of your application by mail or express delivery service to: Technical 
Information Management-PA 04057, Procurement and Grants 
Office, Centers for Disease Control and Prevention (CDC), 2920 
Brandywine Road, Atlanta, GA 30341.
    Applications may not be submitted electronically at this time.

V. Application Review Information

    1. Review: You are required to provide measures of effectiveness 
that will demonstrate the accomplishment of the various identified 
objectives of the grant. Measures of effectiveness must relate to the 
performance goals stated in the ``Purpose'' section of this 
announcement. Measures must be objective and quantitative, and must 
measure the intended outcome. These measures of effectiveness must be 
submitted with the application and will be an element of evaluation.
    2. Review and Selection Process: Applications will be reviewed by 
CDC staff for completeness and responsiveness as outlined under the 
previous heading Application and Submission Information. Incomplete 
applications and applications that are not responsive will be returned 
to the applicant without further consideration.
    Applications which are complete and responsive will be subjected to 
a preliminary evaluation (streamline review) by the Initial Review 
Group (IRG) to determine if the application is of sufficient technical 
and scientific merit to warrant further review by the IRG. Applications 
that are determined noncompetitive will not be considered, and NCIPC 
will promptly notify the investigator/program director and the official 
signing for the applicant organization. Applications determined to be 
competitive will be evaluated by a dual review process.
    Awards will be made based on priority scores assigned to 
applications by the IRG, programmatic priorities and needs determined 
by a secondary review committee (the Advisory Committee for Injury 
Prevention and Control), and the availability of funds.
1. Review by IRG
    An initial streamline peer-review of ICRC grant applications will 
be conducted by the IRG. The IRG may recommend the application for a 
site visit review. For those applications recommended for a site visit 
review, a team of peer reviewers, including members of the IRG, will 
conduct on-site visits at each applicant institution, generate summary 
statements for the visits, and report the assessment to the IRG.
    Factors to be considered by the IRG include:
    a. The specific aims of the application, e.g., the long-term 
objectives and intended accomplishments. Approval of small and large 
research projects (including new research projects proposed during the 
three-year funding cycle), in accordance with NCIPC's performance goal 
as stated in section ``B. Purpose'', is subject to peer review.
    (1) Seed projects will be evaluated collectively on the mechanism 
for solicitation of projects and on their technical/scientific merit 
review. Evaluation criteria have equal value.
    (2) Small projects will be evaluated individually on the 
significance of the

[[Page 66446]]

project, the innovative approach, and the proposed methods for 
achieving an investigation sufficient to support a submission of an RO1 
level proposal and/or worthy of publication in a peer-reviewed journal 
and/or a technical report for a legislative body, governmental agency, 
or injury control program.
    (3) Large projects will be evaluated individually according to 
existing RO1 level project standards as described in the PHS 398 
(Revised 5/01 and updated 6/28/02) guidelines. The application must 
have a minimum of one large research project approved in order to be 
recommended for further consideration.
    (4) At least 80 percent of the costs (total direct and indirect 
costs) of the approved small and large research projects must be in 
alignment with the ``CDC Injury Research Agenda,'' http://www.cdc.gov/ncipc in order to be recommended for further consideration.
    b. The scientific and technical merit of the overall application, 
including the significance and originality (e.g., new topic, new 
method, new approach in a new population, or advancing understanding of 
the problem) of the proposed research.
    c. The extent to which the evaluation plan will allow for the 
measurement of progress toward the achievement of stated objectives. 
Does the application specify how the effectiveness of the program will 
be measured?
    d. Qualifications, adequacy, and appropriateness of personnel to 
accomplish the proposed activities.
    e. The soundness of the proposed budget in terms of adequacy of 
resources and their allocation.
    f. In addition to conducting defined research projects, ICRCs are 
expected to devote substantial attention to advancing the field through 
other activities that are designed to improve research capabilities and 
translate research into practice. Examples of activities include: 
consultation and technical assistance that are responsive to regional, 
State, national, or international priorities; professional training for 
researchers and practitioners; program development; and evaluation 
endeavors. The degree of effort devoted to these aspects of an ICRC's 
program should be clearly stated in the justification and the budget. 
The degree of effort may be varied and should reflect the specific 
focus and goals of the ICRC.
    g. Details of progress in the most recent funding period should be 
provided in the application if the applicant is submitting a re-
competing application. Documented examples of success include: 
Development of pilot projects; completion of high quality research 
projects; publication of findings in peer reviewed scientific and 
technical journals; number of professionals trained; awards received; 
ongoing provision of consultation and technical assistance; integration 
of disciplines; translation of research into implementation; and impact 
on injury control outcomes including legislation, regulation, 
treatment, and behavior modification interventions.
    h. Does the application adequately address the requirements of 
title 45 CFR part 46 for the protection of human subjects?
    i. Does the applicant meet the CDC Policy requirements regarding 
the inclusion of women, ethnic, and racial groups in the proposed 
research? This includes:
    (1) The proposed plan for the inclusion of both sexes, racial and 
ethnic minority populations for appropriate representation.
    (2) The proposed justification when representation is limited or 
absent.
    (3) A statement as to whether the design of the study is adequate 
to measure differences when warranted.
    (4) A statement as to whether the plans for recruitment and 
outreach for study participants include the process of establishing 
partnerships with community or communities and recognition of mutual 
benefits.
    j. Does the application adequately address the requirements of the 
``PHS Policy on Humane Care and Use of Laboratory Animals by Awardee 
Institutions?'
    k. Does the application include measures that are in accordance 
with CDC's performance plans?
2. Review by the CDC Advisory Committee for Injury Prevention and 
Control (ACIPC)
    Secondary review of ICRC grant applications with a priority score 
of 350 or better from the initial peer-review by the IRG will be 
conducted by the Science and Program Review Section (SPRS) of the 
ACIPC. The SPRS consists of ACIPC members, Federal Ex Officio 
participants, and organizational liaisons. The Federal Ex Officio 
participants will be responsible for identifying proposals in 
overlapping areas of research interest so that unwarranted duplication 
in federally funded research can be avoided. The NCIPC Division 
Associate Directors for Science (ADS) or their designees will address 
the SPRS to assure that research priorities of the announcement are 
understood and to provide background regarding current research 
activities. The SPRS recommendations will be presented to the entire 
ACIPC in the form of a report by the Chairman of the SPRS. The ACIPC 
will vote to approve, disapprove, or modify these recommendations for 
funding consideration.
    Factors to be considered by the ACIPC include:
    a. The results of the peer-review.
    b. The significance of the proposed activities as they relate to 
national program priorities, geographic balance, and the achievement of 
national objectives.
    c. The overall balance of the ICRC program in addressing the three 
phases of injury control (prevention, acute care, and rehabilitation); 
the control of injury among populations who are at increased risk, 
including racial/ethnic minority groups, the elderly and children; the 
major causes of intentional and unintentional injury; and the major 
disciplines of injury control.
    d. Budgetary considerations. The ACIPC will recommend annual 
funding levels as detailed in Section II. Award Information, 
Approximate Average Award of this announcement.
    These recommendations, based on the results of the peer review by 
the IRG, the relevance and balance of the proposed research relative to 
the NCIPC programs and priorities, and the assurance of no duplication 
of federally-funded research, are presented to the Director, NCIPC, for 
funding decisions.
    At the discretion of the Director, NCIPC, additional consideration 
may be given to re-competing ICRCs. These centers represent a long-term 
investment for NCIPC and an established resource for injury control-
related issues for their States and regions.
3. Continued Funding
    Continuation awards for new awards to this announcement after 
federal fiscal year 2004 and within the project period will be made on 
the basis of the availability of funds and the following criteria:
    a. The accomplishments of the current budget period show that the 
applicant's objectives as prescribed in the yearly work plans are being 
met.
    b. The objectives for the new budget period are realistic, 
specific, and measurable.
    c. The methods described will clearly lead to achievement of these 
objectives.
    d. The evaluation plan allows management to monitor whether the 
methods are effective by having clearly defined process, impact, and 
outcome objectives, and the applicant demonstrates progress in 
implementing the evaluation plan.

[[Page 66447]]

    e. The budget request is clearly explained, adequately justified, 
reasonable, and consistent with the intended use of grant funds.

VI. Award Administration Information

    1. Award Notices: If your application is to be funded, you will 
receive a Notice of Grant Award (NGA) from the CDC Procurement and 
Grants Office. The NGA shall be the only binding, authorizing document 
between the recipient and CDC. The NGA will be signed by an authorized 
Grants Management Officer, and mailed to the recipient fiscal officer 
identified in the application.
    2. Administrative and National Policy Requirements: 45 CFR parts 74 
and 92.
    For more information on the Code of Federal Regulations, see the 
National Archives and Records Administration at the following Internet 
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
    The following additional requirements apply to this project:

[sbull] AR-1 Human Subjects Requirements
[sbull] AR-2 Requirements for Inclusion of Women and Racial and Ethnic 
Minorities in Research
[sbull] AR-3 Animal Subjects Requirements
[sbull] AR-10 Smoke-Free Workplace Requirements
[sbull] AR-11 Healthy People 2010
[sbull] AR-12 Lobbying Restrictions
[sbull] AR-13 Prohibition on Use of CDC Funds for Certain Gun Control 
Activities
[sbull] AR-20 Conference Support
[sbull] AR-21 Small, Minority, and Women-Owned Business
[sbull] AR-22 Research Integrity
[sbull] AR-25 Release and Sharing of Data

    Starting with the December 1, 2003 receipt date, all NCIPC funded 
investigators seeking more than $250,000 in total costs in a single 
year are expected to include a plan describing how the final research 
data will be shared/released or explain why data sharing is not 
possible. Details on data sharing/release, including the timeliness and 
name of the project data steward, should be included in a brief 
paragraph immediately following the Research Plan Section of the PHS 
398 form. References to data sharing/release may also be appropriate in 
other sections of the application (e.g. background and significance, 
human subjects requirements, etc.) The content of the data sharing/
release plan will vary, depending on the data being collected and how 
the investigator is planning to share the data. The data sharing/
release plan will not count towards the application page limit and will 
not factor into the determination scientific merit or priority scores. 
Investigators should seek guidance from their institutions, on issues 
related to institutional policies, local IRB rules, as well as local, 
state and Federal laws and regulations, including the Privacy Rule.
    Further detail on the requirements for addressing data sharing in 
applications for NCIPC funding may be obtained by contacting NCIPC 
program staff or visiting the NCIPC Internet Web site: at http://www.cdc.gov/ncipc/osp/sharing_policy.htm.
    Additional information on these requirements can be found on the 
CDC web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm.
    3. Reporting:
    You must provide CDC with an original, plus two copies of the 
following reports:
    1. Interim progress report, (PHS 2590, OMB Number 0925-0001, rev. 
5/2001) no less than 90 days before the end of the budget period. The 
progress report will serve as your non-competing continuation 
application, and must contain the following elements:
    a. Current Budget Period Activities Objectives.
    b. Current Budget Period Financial Progress.
    c. New Budget Period Program Proposed Activity Objectives.
    d. Detailed Line-Item Budget and Justification.
    e. Additional Requested Information.
    2. Financial status report, no more than 90 days after the end of 
the budget period.
    3. Final financial and performance reports, no more than 90 days 
after the end of the project period.

VII. Agency Contacts

    For general questions about this announcement, contact: Technical 
Information Management Section, PA 04057, Procurement and 
Grants Office, Centers for Disease Control and Prevention (CDC), 2920 
Brandywine Road, Atlanta, GA 30341, Telephone: 770-488-2700.
    For scientific/research program technical assistance, contact:
    Tom Voglesonger, Program Manager, Office of the Associate Director 
for Science, National Center for Injury Prevention and Control, Centers 
for Disease Control and Prevention (CDC), 4770 Buford Highway, NE, 
(K02), Atlanta, GA 30341-3724, Telephone: (770) 488-4823, Email: 
[email protected].
    For questions about peer review, contact: Gwendolyn Cattledge, PhD, 
Scientific Review Administrator, Office of the Associate Director for 
Science, National Center for Injury Prevention and Control, Centers for 
Disease Control and Prevention (CDC), 4770 Buford Highway, NE, (K02), 
Atlanta, GA 30341-3724, Telephone: (770) 488-1430, E-mail: 
[email protected].
    For financial, grants management, or budget assistance, contact: 
Van King, Grants Management Specialist, Procurement and Grants Office, 
Centers for Disease Control and Prevention (CDC), 2920 Brandywine Road, 
Atlanta, GA 30341, Telephone: (770) 488-2751, E-mail: [email protected].

    Dated: November 20, 2003.
Edward Schultz,
Acting Director, Procurement and Grants Office, Centers for Disease 
Control and Prevention.
[FR Doc. 03-29526 Filed 11-25-03; 8:45 am
BILLING CODE 4163-18-P